Methods: Male mice were divided into treatment six groups (n = 7), namely: Groups I (saline), II and III (cisplatin, 10 mg/kg, i.p.) days, respectively, and IV, V and IV (GEO, 100, 200 and 400 mg/kg/day, respectively, by gavage 3, 4, 5 and 6 days after cisplatin injection). Creatinine levels and protein/creatinine ratio were determined in plasma and urine, respectively. Bone morphogenic protein (BMP-7) and tumor necrosis factor (TNF-α) levels of kidney tissues were determined while mRNA expression levels were obtained using real-time polymerase chain reaction. Results: GEO treatment reduced significantly creatinine levels to 0. 53 ± 0.02; 0.48 ± 0.008 and 0.46 ± 0.02 at 100, 200 and 400 mg/kg, respectively, compared with control (0.70 ± 0.01) [p<0.05] but increased protein : creatinine ratio to 0.21 ± 0.01, 0.22 ± 0.01, 0.24 ± 0.02 compared with control (0.06 ± 0.008) [p<0.05]. Pro-inflammatory TNF-α mRNA expression was decreased to 1.46 ± 0.21, 1.39 ± 0.19 and 1.36 ± 0.09, at GEO doses of 100, 200 and 400 mg/kg, respectively, respectively, compared with control (0.59 ± 0.39, p < 0.05). Conclusion: GEO treatment attenuates cisplatin-induced nephrotoxicity, in part, by modulating some inflammatory cytokines.
INTRODUCTION
Acute kidney injury is a common disorder that develops in approximately 25 % of patients after high-dose cisplatin cancer chemotherapy [1] . Among multiple mechanisms of action, the induction of inflammatory cytokines, oxidative stress, increased creatinine levels, and apoptosis of renal cells are involved in cisplatin-induced nephrotoxicity [2] . Cisplatin initiates the inflammatory process via tumor necrosis factor-α (TNF-α) production by resident and infiltrating immune cells [3] . Several natural products have been used to protect against toxicity induced by drugs and carcinogenic xenobiotics [4] . Different pharmacological activities have also been reported for Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils, including antioxidant, antiinflammatory, antiviral, antibacterial and anticancer effects [5] .
Furthermore, ginger extract suppresses the induction of pro-inflammatory cytokines and chemokine expression produced by synoviocytes, chondrocytes, and leukocytes in humans [6] . A previous study suggested that ginger effectively restores cisplatin-induced delays in gastric emptying in rats [7] . We recently demonstrated that ginger essential oil (GEO) presents anti-inflammatory and immunomodulatory activities in animal models [8] .
Indeed, other studies have demonstrated the reno-protective effects of ginger extract in different experimental models of renal failure [9, 10] .
However, no studies about the reno-protective effects of GEO have been investigated. Therefore, the aim of the present study was to evaluate the effect of GEO in an experimental model of cisplatin-induced nephrotoxicity. 
EXPERIMENTAL Plant material and essential oil extraction

Gas chromatography-mass spectrometry
Gas chromatography (GC) was performed using a Thermo Electron Corporation Focus GC model under the following conditions: DB-5 capillary column (30 m ×0.32 mm. 0.50 mm), column temperature (60 °C for 1 min to 180 °C at 3 °C/min), injector temperature (220 °C), detector temperature (220 °C), split ratio (1:10), carrier gas (He), flow rate (1.0 µl/min). The volume injected was 1 µl diluted in acetone (1:10) . GC/MS analyses were performed using a Quadrupole mass spectrometer (Thermo Electron, DSQ II model) that operated at 70 V. The identification of the individual components was based on a comparison of their GC retention indices obtained with reference to n-alkane series C 8 H 18 -C 20 H 42 (Sigma, St. Louis, MO, USA) on a DB-5 column and comparison with the mass spectra of an authentic standard purchased from Sigma-Aldrich [11] . The retention indices (RI) were obtained with reference to n-alkane C 7 H 16 -C 44 H 90 series (Supelco-Bellefonte USA, UK).
Nuclear magnetic resonance
Nuclear magnetic resonance (NMR) was used to prove the chemical structure of the essential oil constituents identified by CG-MS. 
Drug
Cisplatin was obtained from Darrow Laboratories (Rio de Janeiro, Brazil).
Experimental design
The animals were divided into six groups. Normal group I was injected (i.p.) with saline. Cisplatin (CP) control groups (CTL) II and III were injected with CP (10 mg/kg, i.p.) and in the third and sixth days, respectively, the groups were anesthetized under ketamine (100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) to evaluation of some parameters below described. Groups IV, V, VI were treated with 100, 200 and 400 mg/kg of GEO, respectively, by gavage (3, 4, 5, and 6 days after CP injection) and thereafter anesthetized as CTL groups. Each of the groups had seven animals, with the exception of Group III, which had 18 animals because some of them died between third and sixth days after cisplatin injection.
Analysis of kidney function
Blood was collected directly from the abdominal aorta and then centrifuged. The serum was separated for the determination of serum creatinine levels. Urine was collected from the bladder to measure urinary protein and creatinine levels using a commercial kit (Gold Analisa ® ) for calculating the urinary protein : creatinine ratio.
Quantification of mRNA
Kidney samples were quickly stored in liquid nitrogen. Total RNA was isolated from the kidney using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA), and RNA levels were determined by ultraviolet light absorbance at 260 nm using a Nanodrop 2000C spectrophotometer (Thermo Scientific). First-strand cDNAs were synthesized using MML-V reverse transcriptase (Promega, Madison, WI, USA). Reverse transcription polymerase chain reaction (RT-PCR) was performed using the SYBR Green real-time PCR assay (Applied Biosystems, USA). The following primer sequences were used: TNF-α (sense: 5'-ATG AGC ACA GAA AGC ATG ATCAGC-3'; antisense: 5'-ACG AGG AAT GAG AAG AGG GTC AGA-5'), BMP-7 (sense: 5'-AGA ATT CTT CCA CCC TGC ATA CC-3'; antisense: 5'-TCC TTA TAG ATC CTG AAT TGG GCT-3'). mRNA expression was normalized to hypoxanthine guanine phosphoribosyl transferase (HPRT; sense: 5'-CTC ATG CAC TGA TTA TGG AGA GGA C-3'; antisense: 5'-GCA GGT CAG CAA AGA ACT TAT AGC C-3'), which was used as the housekeeping gene. All data were expressed relative to the expression of the matched controls.
Statistical analysis
The data are expressed as mean ± SEM for each group and were statistically analyzed using oneway analysis of variance (ANOVA) followed by Tukey's test Graph Pad Prism software (version 5). Differences were considered significant at p < 0.05.
RESULTS
The results of the GEO chemical analysis, retention indices, and area percentages are shown in Fig. 1 Table 1 , GEO contained a high amount of α-zingiberene (16.2%), followed by geranial (15.3 %), camphene (9.37 %), neral (7.7 %), β-phellandrene (7.6 %), and (E,E)-α-farnesene (7.4 %), representing a total of 63.5% and indicating a preponderance of terpene (monoterpene) compounds. The presence of numerous other constituents at concentrations ranging from 0.2 to 6.5 % of the essential oil was also observed.
Seric creatinine
Seric creatinine level was significantly elevated on the 3rd (0.65 ± 0.03 mg/dl) and 6th day (0.70 ± 0.01 mg/dl) after cisplatin injection compared with 0.41 ± 0.008 mg/dl for normal control.GEO administration after cisplatin injection decreased significantly creatinine level to 0.53 ± 0.02, 0.48 ± 0.02 and 0.46±0.02 mg/dl at 100, 200 and 400 mg/kg, respectively, on the 6 th day, compared with cisplatin control [p<0.05]., as shown in Fig  2a. 
Urinary protein/creatinine ratio
Urinary protein: creatinine ratio on the 3rd (0.11 ± 0.01 mg/dl) and 6th day (0.06 ± 0.01 mg/dl) after cisplatin injection, was lower than that of normal group (0.41 ± 0.02 mg/dl), reflecting the impairment of renal function. The groups that received GEO at doses of 100, 200 and 400 mg/kg after cisplatin injection increased the ratio to 0.21 ± 0.01, 0.22 ± 0.01, and 0.24 ± 0.02 mg/dl, respectively (Fig 2b, p < 0.05) .
TNF-α mRNA expression levels
The TNF-α gene mRNA expression levels were markedly upregulated on 3rd day (2.47 ± 0.39) and 6th (3.53 ± 0.24) day after cisplatin injection compared with normal group (1.02 ± 0.12) [p<0.05]. The groups that received GEO after cisplatin injection inhibited significantly TNF-α mRNA expression level to 1.46 ± 0.21, 1.39 ± 0.19 and 1.36 ± 0.09 at doses of 100, 200 and 400 mg/kg, respectively, on the 6 th day, compared with control (Fig 3a) .
BMP-7 mRNA expression levels
BMP-7 mRNA expression levels on the 3rd (0.61 ± 0.18) and 6th days (0.59 ± 0.11) after cisplatin injection were significantly lower than that of normal control (6.16 ± 0.68). The groups that received GEO at doses of 200 and 400 mg/kg following cisplatin injection significantly increased BMP-7 mRNA expression level to 2.05 ± 0.26 and 2.44 ± 0.42, respectively, compared with control (p < 0.05). However, there was no significant increase in BMP-7 mRNA expression level in the group that received GEO at a dose of 100 mg/kg (1.35 ± 0.50), as Fig 3b shows. 
DISCUSSION
The present study was aimed at investigating the nephro-protective potentials of ginger essential oil (GEO) against cisplatin-induced toxicity. Renal damage caused by cisplatin depends on the dose and duration of treatment. This study was carried out at a high dose of cisplatin (10 mg/kg/ body weight, i.p) to produce a nephrotoxic effect that corresponds to the dose of cisplatin currently being used in clinical practice. This experimental model is important because accidental cisplatin overdose can be toxic in humans and lead to renal failure [12] .
Besides, GEO presents many biological activities, such as antiinflammatory, antiemetic, and antineoplastic effects, some studies have demonstrated the renoprotective effect [7, 13] . However, this effect has been showed with ginger extracts in nephropathy induced by carbon tetrachloride (CCl 4 ) in rats [7] and against cisplatin-induced nephrotoxicity in mice [13] . In this study, seric creatinine levels were significantly elevated in the control group 3 days and 6 days after cisplatin injection compared with normal control. While GEO administration after cisplatin injection decreased creatinine levels at all test doses 6 days after cisplatin injection.
Hemmelgarn et al [14] showed that chronic kidney disease has a high prevalence of albuminuria and glomerular injury. In this case, albuminuria detection allows therapeutic intervention and the prevention of renal failure. Moreover, urinary protein : creatinine ratio has been shown to be an accurate and reliable method for estimating protein in the urine in many cases, such as in diabetic nephropathy and kidney-transplanted patients [15, 16] . Indeed, acute kidney injury induced by cisplatin administration in rats causes a significative reduction in the glomerular filtration rate and an increase in serum levels of urea and creatinine [17, 18] . In the present study, administration of cisplatin lowered urinary protein:creatinine ratio, reflecting impairment in renal function but the ratio rose following GEO administration. These results indicate the amelioration of kidney function indicators, such as urinary protein and creatinine levels, after administration of GEO in cisplatin-treated mice, as also observed for other natural products [19, 20] .
Increasing evidence suggest the involvement of inflammatory processes in renal injury, including expression of genes that encode proinflammatory cytokines, such as TNF-α, interleukin 6 (IL-6), IL-1β, and transforming growth factor β, which potentiate inflammation [21] . Previous studies suggested that TNF-α inhibition ameliorates cisplatin-induced renal disfunction [22] . Some natural products have been reported to suppress inflammatory processes by inhibiting the production of TNF-α and IL-1β. In this regard, ginger extract has been demonstrated to inhibit proinflammatory cytokine (TNF-α, IL-1β) and cyclooxygenase-2 enzyme expression in TNF-α-, IL-1β, or lipopolysaccharide-induced THP-1 cells [23] . Our data show that TNF-α gene was markedly upregulated after cisplatin injection and that GEO administration inhibited TNF-α mRNA expression level at all the tested doses, suggesting that the reno-protective effect of GEO may be attributable to inhibition of pro-inflammatory cytokines, such as TNF-α and IL-1β.
Bone morphogenetic protein-7 (BMP-7) has been shown to participate in organ development, regeneration, and wound healing and has diverse biological functions. Over-expression of renal BMP-7 is capable of inhibiting TGF-β/Smad3 signaling and protecting the kidney from TGF-α-mediated renal injury [24] . BMP-7 can suppress TNF-α-induced inflammatory responses during nephropathy by inhibiting the activity of nuclear factor-κB and increasing the activity of peroxisomal proliferator-activated receptor-γ in an immunoglobulin A-induced nephropathy model [20] . In our study, we observed that GEO treatment increases BMP-7 mRNA expression. BMP-7 has been reported to protect against ischemic injury by acting on proximal tubular epithelial cells to reduce TNF-α, IL-6, and IL-1β expression [25] .
CONCLUSION
GEO treatment has beneficial effects in an experimental mice model of cisplatin-induced nephrotoxicity, as reflected by decreased creatinine levels and increase in the protein : creatinine ratio. GEO also inhibits the expression of pro-inflammatory TNF-α cytokine levels and protects against ischemic injury by increasing BMP-7 expression. Thus, GEO treatment may poessess potential benefits to renal patients. However, further investigations are essential to elucidate the mechanism by which GEO treatment ameliorates the nephrotoxicity.
